Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Current Opinion in Chemical Biology|August 28, 2003
Advances in pain therapeuticsPhilip LoGrasso, Jeffrey McKelvyMini Reviews in Medicinal Chemistry|August 5, 2008
Inhibitors of c-jun-N-terminal kinase (JNK)Philip LoGrasso, Theodore KameneckaArchives of Biochemistry and Biophysics|June 19, 2008
Mechanistic characterization for c-jun-N-Terminal Kinase 1alpha1Brian Ember, Philip LoGrassoBiochemistry|February 14, 2008
Kinetic mechanism and inhibitor characterization for c-jun-N-terminal kinase 3alpha1Brian Ember, Ted Kamenecka, Philip LoGrassoBiochemical and Biophysical Research Communications|July 22, 2008
Detection of myosin light chain phosphorylation--a cell-based assay for screening Rho-kinase inhibitorsThomas Schröter, Evelyn Griffin, Amiee Weiser, et al.Archives of Biochemistry and Biophysics|May 24, 2005
Substituting c-Jun N-terminal kinase-3 (JNK3) ATP-binding site amino acid residues with their p38 counterparts affects binding of JNK- and p38-selective inhibitorsMichael Fricker, Philip Lograsso, Semantha Ellis, et al.Archives of Biochemistry and Biophysics|August 15, 2002
Characterization and purification of truncated human Rho-kinase II expressed in Sf-21 cellsMary S Turner, Fen-Fen-Lin, John W Trauger, et al.Scientific Reports|January 28, 2015
Structural basis and biological consequences for JNK2/3 isoform selective aminopyrazolesHaJeung Park, Sarah Iqbal, Pamela Hernandez, et al.ACS Chemical Neuroscience|June 14, 2011
JNK Inhibition Protects Dopamine Neurons and Provides Behavioral Improvement in a Rat 6-hydroxydopamine Model of Parkinson's DiseaseCandice E Crocker, Susan Khan, Michael D Cameron, et al.Bioorganic & Medicinal Chemistry Letters|October 4, 2007
3,5-Disubstituted quinolines as novel c-Jun N-terminal kinase inhibitorsRong Jiang, Derek Duckett, Weiming Chen, et al.Pageof 3